Controversy Surrounds Palantir's NHS Contract Amid Calls for Cancellation

Members of Parliament (MPs) from the Labour and Liberal Democrat parties have intensified their calls for the UK government to terminate its £330 million contract with the American technology firm Palantir, which is responsible for the NHS federated data platform (FDP). During a recent debate, MPs labeled the contract as “dreadful” and “shameful,” expressing concerns over Palantir's trustworthiness in handling sensitive health data. Labour MP Samantha Niblett questioned whether Palantir could be trusted as a custodian of the health records of millions of British citizens, while Liberal Democrat MP Luke Taylor insisted that the company must be removed from the NHS before it is too late.

The Guardian

In response to the mounting pressure, the government indicated it would reassess the contract when a break clause comes due in spring 2027, although £210 million of the total contract value has already been expended. Junior Health Minister Dr. Zubir Ahmed acknowledged the criticisms but noted that the FDP is exceeding its performance targets. He stated, “We are no fan of [Palantir’s] politics. However, the FDP and the principles that underpin it are critical to the future of the NHS.”

The Guardian

Palantir has been actively countering the negative sentiment surrounding its contract through a public relations campaign, advised by political strategist Isaac Levido. Internal documents obtained under the Freedom of Information Act reveal that NHS England is focused on combating misinformation and has considered launching a podcast to promote the FDP. However, there are concerns about the effectiveness of the system, with some NHS officials expressing that the tools are not industry standard and that their concerns are being overlooked.

The Guardian

Despite Palantir's claims of delivering 110,000 additional operations and reducing discharge delays, its reputation remains a significant hurdle. A briefing note to Health Secretary Wes Streeting highlighted that Palantir's public image could hinder further progress with the FDP.

The Guardian

Critics of Palantir have voiced concerns about vendor lock-in, data security, and the overall value for money of the contract. Dame Chi Onwurah, chair of the Commons Science and Technology Committee, emphasized that the criticisms are based on legitimate concerns rather than ideological opposition. In contrast, Louis Mosley, the UK head of Palantir, has dismissed critics as prioritizing ideology over patient safety.

The Guardian

NHS England has reiterated its commitment to ensuring patient data remains protected while emphasizing the benefits of the FDP in improving care and reducing waiting times. A spokesperson stated, “There is no intention to launch a podcast,” countering suggestions that such a move was in the works. Palantir has also defended its software, asserting that it operates under the control of the NHS and is meeting its project milestones.

The Guardian

• “Palantir and Peter Thiel must have their hands ripped off of our NHS before it is too late.” — Luke Taylor, Liberal Democrat MP

The Guardian

• “The main issue is trust,” — Martin Wrigley, Liberal Democrat MP

The Guardian

• “While the noise continues, the software works.” — Louis Mosley, UK Head of Palantir

The Guardian

The debate over Palantir's contract with the NHS highlights significant concerns regarding data privacy, trust, and the implications of using a controversial company in the public health sector. As the government prepares for a future review of the contract, the outcome will likely have lasting implications for the NHS and its relationship with technology providers.

The Guardian